148 related articles for article (PubMed ID: 37905747)
1. Intestinal ultrasound score predicts therapeutic outcomes of infliximab in pediatric patients with Crohn's disease.
Wang L; Zhang Y; Wu H; Tang Z; Wang Y; Huang Y
Scand J Gastroenterol; 2024; 59(2):156-163. PubMed ID: 37905747
[TBL] [Abstract][Full Text] [Related]
2. Correlation of Ultrasound Scores with Endoscopic Activity in Crohn's Disease: A Prospective Exploratory Study.
Dragoni G; Gottin M; Innocenti T; Lynch EN; Bagnoli S; Macrì G; Bonanomi AG; Orlandini B; Rogai F; Milani S; Galli A; Milla M; Biagini MR
J Crohns Colitis; 2023 Oct; 17(9):1387-1394. PubMed ID: 37023010
[TBL] [Abstract][Full Text] [Related]
3. External validation and comparison of simple ultrasound activity score and international bowel ultrasound segmental activity score for Crohn's disease.
Wang L; Xu C; Zhang Y; Jiang W; Ma J; Zhang H
Scand J Gastroenterol; 2023; 58(8):883-889. PubMed ID: 36825305
[TBL] [Abstract][Full Text] [Related]
4. Ultrasonographic scores for ileal Crohn's disease assessment: Better, worse or the same as contrast-enhanced ultrasound?
Freitas M; de Castro FD; Macedo Silva V; Arieira C; Cúrdia Gonçalves T; Leite S; Moreira MJ; Cotter J
BMC Gastroenterol; 2022 May; 22(1):252. PubMed ID: 35585503
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic accuracy of different cross-sectional imaging techniques for disease location and activity in Crohn's disease and external validation and comparison of MARIAs and IBUS-SAS.
Xu C; Li L; Zhang Y; Wang R; Zhang H
Abdom Radiol (NY); 2023 Mar; 48(3):821-832. PubMed ID: 36525049
[TBL] [Abstract][Full Text] [Related]
6. Baseline and Postinduction Intestinal Ultrasound Findings Predict Long-term Transmural and Mucosal Healing in Patients With Crohn's Disease.
Huang Z; Cheng W; Chao K; Tang J; Li M; Guo Q; Liu G; Gao X
Inflamm Bowel Dis; 2023 Oct; ():. PubMed ID: 37889843
[TBL] [Abstract][Full Text] [Related]
7. Ultrasound remission after biologic induction and long-term endoscopic remission in Crohn's disease: a prospective cohort study.
Allocca M; Dell'Avalle C; Zilli A; Furfaro F; D'Amico F; Jairath V; Rubin DT; Peyrin-Biroulet L; Fiorino G; Danese S
EClinicalMedicine; 2024 May; 71():102559. PubMed ID: 38549587
[TBL] [Abstract][Full Text] [Related]
8. Intestinal Ultrasound Early on in Treatment Follow-up Predicts Endoscopic Response to Anti-TNFα Treatment in Crohn's Disease.
de Voogd F; Bots S; Gecse K; Gilja OH; D'Haens G; Nylund K
J Crohns Colitis; 2022 Nov; 16(10):1598-1608. PubMed ID: 35639823
[TBL] [Abstract][Full Text] [Related]
9. Multimodal dynamic ultrasound approach as predictor of response in patients with Crohn's disease treated with ustekinumab.
Ainora ME; Liguori A; Mignini I; Cintoni M; Galasso L; Laterza L; Lopetuso LR; Garcovich M; Riccardi L; Gasbarrini A; Scaldaferri F; Zocco MA
Therap Adv Gastroenterol; 2024; 17():17562848241259289. PubMed ID: 38912296
[TBL] [Abstract][Full Text] [Related]
10. Intestinal Ultrasound Combined with Blood Inflammatory Markers Is a More Efficient Tool in Evaluating Severity of Crohn's Disease: A Pilot Study.
Fang H; Liu J; Qian K; Xu X; Li Z; Xie L; Sun M; Wang S; Xu J; Lv C; Wang B; Liu W; Song G; Yu Y
Gastroenterol Res Pract; 2023; 2023():2173396. PubMed ID: 38024525
[TBL] [Abstract][Full Text] [Related]
11. [Value of different endoscopic scoring methods in assessing disease activity in pediatric Crohn's disease].
Deng W; Li ZY; Liu B
Zhongguo Dang Dai Er Ke Za Zhi; 2024 Jun; 26(6):584-591. PubMed ID: 38926374
[TBL] [Abstract][Full Text] [Related]
12. Validation of endoscopic activity scores in patients with Crohn's disease based on a post hoc analysis of data from SONIC.
Ferrante M; Colombel JF; Sandborn WJ; Reinisch W; Mantzaris GJ; Kornbluth A; Rachmilewitz D; Lichtiger S; D'Haens GR; van der Woude CJ; Danese S; Diamond RH; Oortwijn AF; Tang KL; Miller M; Cornillie F; Rutgeerts PJ;
Gastroenterology; 2013 Nov; 145(5):978-986.e5. PubMed ID: 23954314
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the infliximab therapy of severe form of pediatric Crohn's disease in Poland: Retrospective, multicenter studies.
Iwańczak BM; Ryżko J; Jankowski P; Sładek M; Wasilewska A; Szczepanik M; Sienkiewicz E; Szaflarska-Popławska A; Więcek S; Czaja-Bulsa G; Korczowski B; Maślana J; Iwańczak F; Kacperska M
Adv Clin Exp Med; 2017; 26(1):51-56. PubMed ID: 28397432
[TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance enterography changes after antibody to tumor necrosis factor (anti-TNF) alpha therapy in Crohn's disease: correlation with SES-CD and clinical-biological markers.
Stoppino LP; Della Valle N; Rizzi S; Cleopazzo E; Centola A; Iamele D; Bristogiannis C; Stoppino G; Vinci R; Macarini L
BMC Med Imaging; 2016 May; 16(1):37. PubMed ID: 27149857
[TBL] [Abstract][Full Text] [Related]
15. Infliximab trough level combined with inflammatory biomarkers predict long-term endoscopic outcomes in Crohn's disease under infliximab therapy.
Cao WT; Huang R; Liu S; Fan YH; Xu MS; Xu Y; Ni H
World J Gastroenterol; 2022 Jun; 28(23):2582-2596. PubMed ID: 35949356
[TBL] [Abstract][Full Text] [Related]
16. Assessment of endoscopic response using pan-enteric capsule endoscopy in Crohn's disease; the Sensitivity to Change (STOC) study.
Volkers A; Bossuyt P; de Jong J; Pouillon L; Gecse K; Duijvestein M; Ponsioen C; D'Haens G; Löwenberg M
Scand J Gastroenterol; 2022 Apr; 57(4):439-445. PubMed ID: 34968158
[TBL] [Abstract][Full Text] [Related]
17. Early Ultrasound Response and Progressive Transmural Remission After Treatment With Ustekinumab in Crohn's Disease.
Kucharzik T; Wilkens R; D'Agostino MA; Maconi G; Le Bars M; Lahaye M; Bravatà I; Nazar M; Ni L; Ercole E; Allocca M; Machková N; de Voogd FAE; Palmela C; Vaughan R; Maaser C;
Clin Gastroenterol Hepatol; 2023 Jan; 21(1):153-163.e12. PubMed ID: 35842121
[TBL] [Abstract][Full Text] [Related]
18. Determining the Accuracy of Intestinal Ultrasound Scores as a Prescreening Tool in Crohn's Disease Clinical Trials.
Dolinger MT; Aronskyy I; Kellar A; Gao M; Spencer EA; Pittman N; Dubinsky MC
Am J Gastroenterol; 2024 May; 119(5):930-936. PubMed ID: 38131626
[TBL] [Abstract][Full Text] [Related]
19. Intestinal Ultrasound and MRI for Monitoring Therapeutic Response in Luminal Crohn's Disease: A Systematic Review.
Lovett GC; Schulberg JD; Hamilton AL; Wilding HE; Kamm MA; Wright EK
J Am Coll Radiol; 2024 Mar; 21(3):441-463. PubMed ID: 37852561
[TBL] [Abstract][Full Text] [Related]
20. Development and Validation of a Test to Monitor Endoscopic Activity in Patients With Crohn's Disease Based on Serum Levels of Proteins.
D'Haens G; Kelly O; Battat R; Silverberg MS; Laharie D; Louis E; Savarino E; Bodini G; Yarur A; Boland BS; Afif W; Li XJ; Hale M; Ho J; Kondragunta V; Huang B; Kuy C; Okada L; Hester KD; Bray KR; Mimms L; Jain A; Singh S; Collins A; Valasek MA; Sandborn WJ; Vermeire S; Dulai PS
Gastroenterology; 2020 Feb; 158(3):515-526.e10. PubMed ID: 31711925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
